GLP1R and hyperinsulinism: The study authors proposed that increased insulin levels in atypical hyperinsulinism may be driven by increased incretin action, specifically GLP-1, and propose that GLP-1 can be utilized as a biomarker to help identify and diagnose atypical hyperinsulinism (29), however, these findings need to be replicated in a larger population.